PlexBio Co., Ltd. (TPEX:6572)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
7.30
-0.09 (-1.22%)
Jun 18, 2026, 2:56 PM CST
Market Cap756.64M -34.8%
Revenue (ttm)127.10M -0.8%
Net Income-62.47M
EPS-0.60
Shares Out 103.65M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume178,222
Open7.25
Previous Close7.39
Day's Range6.96 - 7.33
52-Week Range5.16 - 15.80
Beta1.07
Analystsn/a
Price Targetn/a
Earnings DateAug 14, 2026

About PlexBio

PlexBio Co., Ltd. develops and manufactures in vitro diagnostic reagents for molecular biology and immunology projects. It offers workflow navigation services; automated sample preparation kits; IntelliPlex platform that is designed for πCode technology with throughput sample-to-answer multiplexing assays; oncology assays, a portfolio for advanced molecular testing; and πCode coupling buffer sets. PlexBio Co., Ltd. was founded in 2009 and is based in Taipei, Taiwan. [Read more]

Sector Healthcare
Founded 2009
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 6572
Full Company Profile

Financial Performance

In 2025, PlexBio's revenue was 127.10 million, a decrease of -0.76% compared to the previous year's 128.06 million. Losses were -62.47 million, 1.36% more than in 2024.

Financial Statements